// App-Quantinova.ai

17175 : Phoshodiesterase 2 - A New Member Of Proteins Involved In Beta-adrenergic Desensitization

Researchers

Presenter

  • Hind Mehel

Principal Investigators

  • Florence Lefebvre

  • Audrey Varin

  • Thomas Eschenhagen

  • Stanley Nattel

  • Dobromir Dobrev

  • Wolfram-Hubertus Zimmermann

  • Viacheslav O Nikolaev

  • Gregoire Vandecasteele

  • Rodolphe Fischmeister

  • Ali El-Armouche

  • Katrin Wittkoepper

  • Danilo Seppelt

  • Matthias Dewenter

  • Susanne Lutz

  • Samuel Sossalla

  • Lars S Maier

  • Patrick Lechene

  • Jerome Leroy

Medical Centers

  • University of Montreal, Montreal, QC, Canada

  • University Medical Center Goettingen, Gottingen, Germany

  • Universite Paris Sud, Chatenay Malabry, France

  • University Medical Center Hamburg Eppendorf, Hamburg, Germany

  • University of Duisburg-Essen, Essen, Germany

Locations

  • France

  • Canada

  • Germany

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

Disease

  • Advanced heart failure

Biomarkers

  • Cyclic adenosine monophosphate

Drug/Treatment

  • Isoproterenol

  • Dobutamine

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim